NEJM Group

NEJM Interviews

Health EN ↓ 959 episodes

Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.

Be sure to visit the podcast's website and support the creator: www.nejm.org

Author

NEJM Group

Episodes

NEJM Interview: Dr. Robert Truog on issues in medical ethics and the physician-patient relationship. 15.02.2012 21:39

Dr. Robert Truog is a professor of medical ethics, anesthesiology, and pediatrics at Harvard Medical School and a senior associate in critical care medicine at Children's Hospital Boston. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. R.D. Truog. 200th Anniversary Article: Patients and Doctors - The Evolution of a Relationship. N Engl J Med 2012;366:581-5.

NEJM Interview: Dr. Pieter Cohen on the regulation of dietary supplements. 01.02.2012 17:33

Dr. Pieter Cohen is a primary care physician at Cambridge Health Alliance in Somerville, Massachusetts, and an assistant professor of medicine at Harvard Medical School. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. P.A. Cohen. Assessing Supplement Safety - The FDA's Controversial Proposal. N Engl J Med 2012;366:389-91.

NEJM Interview: Michael Chernew on the Medicare's physician-payment system and the sustainable growth rate (SGR) formula. 25.01.2012 10:46

Michael Chernew is a professor of health care policy in the Department of Health Care Policy at Harvard Medical School. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. A. Alhassani, A. Chandra, and M.E. Chernew. The Sources of the SGR "Hole". N Engl J Med 2012;366:289-91.

NEJM Interview: Cynthia Jackevicius on generic drugs and health care costs. 18.01.2012 10:33

Cynthia Jackevicius is an associate professor of pharmacy practice at Western University of Health Sciences in Pomona, California, and an assistant professor in the Department of Health Policy, Management and Evaluation at the University of Toronto. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. C.A. Jackevicius et al. Generic Atorvastatin and Health Care Costs. N Engl...

NEJM Interview: I. Glenn Cohen on the constitutional challenge of the Affordable Care Act that will heard by the United States Supreme Court in March. 11.01.2012 19:17

I. Glenn Cohen is an Assistant Professor and Co-Director, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, both at Harvard Law School. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. I.G. Cohen and J.F. Blumstein. The Constitutionality of the ACA's Medicaid-Expansion Mandate. N Engl J Med 2012;366:103-4.

NEJM Interview: Allan Brandt on the history of the Journal as a window into the history of medicine, science, and society. 04.01.2012 22:26

Allan Brandt is a Professor of the History of Medicine at Harvard Medical Schooland Dean of the Graduate School of Arts and Sciences at Harvard University. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. Brandt A. A Reader's Guide to 200 Years of the New England Journal of Medicine. N Engl J Med 2012;366:1-7.

NEJM Interview: Dr. Robert Schwartz on the history of cancer research. 21.12.2011 12:51

Dr. Robert Schwartz is a professor emeritus of medicine at Tufts Medical School, and a former deputy editor at the Journal, both in Boston. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. Supplement to: Schwartz R. The Emperor of All Maladies - The Beginning of the Beginning. N Engl J Med 2011;365:2353-5.

NEJM Interview: Dr. Elliot Israel on the risks and benefits of long-acting beta agonists in the treatment of asthma and COPD. 14.12.2011 16:16

Dr. Elliot Israel is a Professor of Medicine at Harvard Medical School and the Director of Clinical Research in the Pulmonary and Critical Care Division at Brigham and Women's Hospital, both in Boston. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. Supplement to: Chowdhury B et al. The Risks and Benefits of Indracaterol - The FDA's Review. N Engl J Med 2011;365:2247-9.

NEJM Interview: Dr. Jerry Avorn on the evolving approach to drug safety in the United States 07.12.2011 15:13

Dr. Jerry Avorn is Professor of Medicine at Harvard Medical School and Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital, both in Boston. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. Supplement to: Avorn J. Learning about the Safety of Drugs - A Half-Century of Evolution. N Engl J Med 2011;365:2151-3.